¹Ù·Î°¡±â ¸Þ´º

¹Ù·Î°¡±â ¸Þ´º º»¹®³»¿ë ¹Ù·Î°¡±â ¸ÞÀθ޴º ¹Ù·Î°¡±â

ÁÖ¿ä¾È³»

HOME »çÀÌÆ®¸Ê

FONT SIZE

ÆùƮũ±â Å°¿ò 100% 110% 120% 130% 140% ÆùƮũ±â ÁÙÀÓ
¸Þ´ºº¸±â
 
Á¦¸ñ
1/22 ¹ßÇ¥³í¹®ÀÔ´Ï´Ù.
ÀÛ¼ºÀÏ
2021-01-22
Á¶È¸¼ö
267


¾È³çÇϼ¼¿ä, ³ª·¡ÀÔ´Ï´Ù.

Á¦°¡ À̹øÁÖ¿¡ ¹ßÇ¥ÇÏ°Ô µÉ ³í¹®Àº 2018³â immunity¿¡ °³Á¦µÈ 
"B Cells Are the Dominant Antigen-Presenting Cells that Activate Naive CD4+ T Cells upon Immunization with a Virus-Derived Nanoparticle Antigen"À̶ó´Â Á¦¸ñÀÇ ³í¹®À¸·Î,
antigenÀÌ virus like particle(VLP)ÀÏ °æ¿ì CD4+ T cellÀÌ Dendritic cell°ú´Â independentÇÏ°Ô B cellÀÇ antigen presentationÀ» ÅëÇØ È°¼ºÈ­ µÈ´Ù´Â ³»¿ëÀÇ ³í¹®À¸·Î B cellÀÇ antigen presentation ¿ªÇÒ¿¡ ´ëÇØ ¹àÈù ³»¿ëÀÔ´Ï´Ù.

ÀÌ·¯ÇÑ Çö»óÀº Á¶Á÷ ¸»´Ü ÁÖ·Î ºÐÆ÷µÇ¾îÀÖ´Â DC¸¦ °ÅÄ¡Áö ¸øÇÏ°í Ç÷¾×À» ÅëÇØ ºü¸£°Ô spleenÀÇ B cell follicle·Î µµ´ÞÇÏ´Â ¹ÙÀÌ·¯½ºÀÇ Æ¯¼º°úµµ ¸Â¹°·ÁÀÖ¾î ¹ÙÀÌ·¯½º °¨¿°½Ã Àü¹ÝÀûÀÎ ¸é¿ª ½Ã½ºÅÛÀÇ È°¼ºÀ» ÀÌÇØÇϴµ¥ µµ¿òÀÌ µÉ °Í °°¾Æ ¼Ò°³µå¸®°íÀÚ ¼±Á¤ÇÏ°Ô µÇ¾ú½À´Ï´Ù.

¿­½ÉÈ÷ ÁغñÇÏ¿© ¹ßÇ¥½Ã ºË°Ú½À´Ï´Ù.

³ª·¡ ¿Ã¸².

»çÀÌÆ® ¸µÅ©: https://www.sciencedirect.com/science/article/pii/S1074761318303534?via%3Dihub
÷ºÎÆÄÀÏ:
÷ºÎÆÄÀÏÀÌ ¾ø½À´Ï´Ù.
´ÙÀ½±Û
1/30 ¹ßÇ¥ ³í¹®ÀÔ´Ï´Ù.
/ °ü¸®ÀÚ
¾È³çÇϼ¼¿ä. ¿ìÁøÀÔ´Ï´Ù. À̹øÁÖ Á¦°¡ ¹ßÇ¥ÇÒ ³í¹®Àº ÀÌ ´Þ 7ÀÏ, Cell¿¡ °ÔÀçµÈ 'Synergism of TNF-a and IFN-g triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and Cytokine Shock syndromes' ÀÔ´Ï´Ù. Covid-19, sepsis, hemophagocytic lymphohistiocytosis µî¿¡ ..
ÀÌÀü±Û
1/22 ¹ßÇ¥ ³í¹®ÀÔ´Ï´Ù.
/ °ü¸®ÀÚ
¾È³çÇϼ¼¿ä ö±ÕÀÔ´Ï´Ù. À̹øÁÖ Åä¿äÀÏ¿¡ ¹ßÇ¥µå¸± ³í¹®ÀÇ Á¦¸ñÀº "Modularly Programmable Nanoparticle Vaccine Based onPolyethyleneimine for Personalized Cancer Immunotherapy" À̸ç À̹ø´Þ¿¡ Advanced science ¿¡ ÃâÆÇµÈ ³í¹®ÀÔ´Ï´Ù. PEI¸¦ ±â¹ÝÀ¸·Î PEGlyationÀ» ÅëÇØ µ¶¼ºÀ» ÃÖ¼ÒÈ­ÇÏ°í, neoan..